CIK 0001468748 · Non-accelerated filer<br>Smaller reporting company
Kodiak Sciences Inc.
Sign in to watch- Ticker
- KOD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270476525
- Phone
- 650-281-0850
- Business address
- 1250 PAGE MILL RD, PALO ALTO, CA, 94304
- Former names
- Oligasis, LLC
- Open-market buys, last 90 days
- $181,327,230
- in 4 filings
- Open-market sales, last 90 days
- $2,700,322
- in 1 filing, $2.7M under 10b5-1 plans
Net +$178,626,907. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-24 | BAKER BROS. ADVISORS LP Director | Purchase | +523 | $56.62 | $30K | 929,967 |
| 2020-02-24 | BAKER BROS. ADVISORS LP Director | Purchase | +5,804 | $56.62 | $329K | 10,136,759 |
| 2020-02-24 | BAKER BROS. ADVISORS LP Director | Purchase | +1,921 | $56.69 | $109K | 931,888 |
| 2020-02-24 | BAKER BROS. ADVISORS LP Director | Purchase | +21,301 | $56.69 | $1.2M | 10,158,060 |
| 2020-02-24 | BAKER BROS. ADVISORS LP Director | Purchase | +323 | $57.62 | $19K | 932,211 |
| 2020-02-24 | BAKER BROS. ADVISORS LP Director | Purchase | +3,577 | $57.62 | $206K | 10,161,637 |
| 2020-02-24 | BAKER BROS. ADVISORS LP Director | Purchase | +642 | $58.39 | $37K | 932,853 |
| 2020-02-24 | BAKER BROS. ADVISORS LP Director | Purchase | +7,122 | $58.39 | $416K | 10,168,759 |
| 2020-02-24 | BAKER BROS. ADVISORS LP Director | Purchase | +612 | $58.54 | $36K | 933,465 |
| 2020-02-24 | BAKER BROS. ADVISORS LP Director | Purchase | +6,788 | $58.54 | $397K | 10,175,547 |
| 2020-02-24 | BAKER BROS. ADVISORS LP Director | Purchase | +777 | $60.77 | $47K | 934,242 |
| 2020-02-24 | BAKER BROS. ADVISORS LP Director | Purchase | +8,623 | $60.77 | $524K | 10,184,170 |
| 2019-12-30 | Liang Hong SVP, Discovery Medicine | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2019-12-30 | EHRLICH JASON See Remarks | Grant or award · Stock Option (Right to Buy) | +93,000 | 93,000 | ||
| 2019-12-30 | BORGESON JOHN A. See Remarks | Grant or award · Stock Option (Right to Buy) | +67,500 | 67,500 | ||
| 2019-12-30 | PERLROTH VICTOR Chairman, President and CEO | Grant or award · Stock Option (Right to Buy) | +241,500 | 241,500 | ||
| 2019-12-23 | EHRLICH JASON See Remarks | Option exercise | +1,075 | $10.29 | $11K | 22,542 |
| 2019-12-23 | EHRLICH JASON See Remarks | Option exercise · Stock Option (Right to Buy) | −1,075 | 423,925 | ||
| 2019-12-18 | EHRLICH JASON See Remarks | Option exercise | +30,000 | 30,000 | ||
| 2019-12-18 | EHRLICH JASON See Remarks | Shares withheld for taxes | −8,533 | $15.51 | $132K | 21,467 |
Page 34 of 37 · 722 trades